← Open Payments lookup

KEVIN PENO: Open Payments

NPI 1104430503 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,320 in 89 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $493 · 2025 $1,320

Food & beverage: $1,320
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$284
ABBVIE INC.18$227
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$203
E.R. Squibb & Sons, L.L.C.11$169
Takeda Pharmaceuticals U.S.A., Inc.5$85
Collegium Pharmaceutical, Inc.4$80
Lundbeck LLC3$56
Neurocrine BioSciences, Inc.3$51
Otsuka Pharmaceutical Development & Commercialization, Inc.2$49
Alkermes, Inc.2$43

Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, ABILIFY MAINTENA, TRINTELLIX, Jornay PM, INGREZZA.

Industry payments across PA — which companies pay providers there.